|
KMID : 0043320110340040599
|
|
Archives of Pharmacal Research
2011 Volume.34 No. 4 p.599 ~ p.606
|
|
|
Characterization and biodistribution of human mesenchymal stem cells transduced with lentiviral-mediated BMP2
|
|
Choi Kyoung-Suk
Ahn Soon-Young
Kim Tek-Seung
Kim Ji-Seon
Kim Byoung-Guk
Han Kyung-Ho
Ban Sang-Ja
Kim Hyung-Soo
Choi Young-Ju
Lim Chul-Joo
|
|
|
Abstract
|
|
|
|
Recently, the genetic modification of mesenchymal stem cells (MSCs) has led to increased differentiation potential. For the therapeutic application of genetically modified MSCs, it is crucial to evaluate their characteristics and safety. In this study, we investigated the effects of bone morphogenetic protein 2 (BMP2) gene transfer on the characteristics and biodistribution of human MSCs. Lentiviral-mediated BMP2 transduction to MSCs enhanced osteocyte differentiation and decreased adipocyte differentiation. Although there is no significant difference in cell proliferation capacity, MSCs transduced BMP2 proliferate somewhat higher than nontransduced or GFP transduced MSCs. No significant changes were observed in surface antigen expression in genetically modified MSCs. In vivo transplantation of lentiviral-mediated BMP2 gene transferred MSCs to nude mice did not result in tumor formation. To evaluate the biodistribution of genetically modified cells, MSCs carrying BMP2 were injected into the tail vein of femur fractured mice. The introduced MSCs were detected in the spleen, testis and fractured femur 28 days post-implantation. These findings suggest that diverse safety tests for genetically modified MSCs should be considered, particularly when a lentivirus mediated gene transfer method is used.
|
|
|
KEYWORD
|
|
|
MSCs, BMP2, Characterization, Lentivirus
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|